1. Efficacy and Safety of Regorafenib Combined with Toripalimab in the Third-Line and beyond Treatment of Advanced Colorectal Cancer. (24th September 2021) Authors: Yu, Wei; Tao, Qiaomeng; Zhang, Yufeng; Yi, Fengming; Feng, Long Other Names: Singh Chandra Academic Editor. Journal: Journal of oncology Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The benefits and risks of CTLA4 inhibitor plus PD1/PDL1 inhibitor in stage IIIB/IV non‐small cell lung cancer: A systematic analysis and meta‐analysis based on randomized controlled trials. (8th June 2021) Authors: Liu, Qiangyun; Fang, Zige; Liu, Miaowen; Xu, Ruoxin; Yi, Fengming; Wei, Yiping; Zeng, Linxiang; Zhang, Wenxiong Journal: Journal of clinical pharmacy and therapeutics Issue: Volume 46:Number 6(2021) Page Start: 1519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparison of transcatheter arterial chemoembolization combined with radiofrequency ablation or microwave ablation for the treatment of unresectable hepatocellular carcinoma: a systemic review and meta-analysis. (1st January 2020) Authors: Zhao, Jiani; Wu, Jianxin; He, Mengyu; Cao, Menghao; Lei, Jun; Luo, Hongliang; Yi, Fengming; Ding, Jingli; Wei, Yiping; Zhang, Wenxiong Journal: International journal of hyperthermia Issue: Volume 37:Number 1(2020) Page Start: 624 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparison of Different First-Line Systemic Therapies in Advanced Biliary Tract Cancer Based on Updated Random Controlled Trials: A Systematic Review and Network Meta-Analysis. (9th September 2022) Authors: Feng, Long; Wang, Ying; Xu, Haoqian; Yi, Fengming Other Names: Wang Bing Academic Editor. Journal: BioMed research international Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Preoperative Serum Platelet-Lymphocyte Ratio as a Prognostic Factor in Cholangiocarcinoma Patients after Radical Resection: A Retrospective Analysis of 119 Patients. (28th January 2019) Authors: Wu, Ying; Zhou, Danyang; Zhang, Guoping; Yi, Fengming; Feng, Long Other Names: Hawinkels Lukas J.A.C. Academic Editor. Journal: Gastroenterology research and practice Issue: Volume 2019(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Nivolumab provides improved effectiveness and safety compared with docetaxel as a second‐line treatment for advanced non‐small cell lung cancer: A systematic review and meta‐analysis. (9th January 2019) Authors: Xu, Zheng; Yi, Fengming; Yu, Dongliang; Xu, Jianjun; Wei, Yiping; Zhang, Wenxiong Journal: Cancer medicine Issue: Volume 8:Number 2(2019:Feb.) Page Start: 629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. High Intestinal and Systemic Levels of Interleukin-23/T-Helper 17 Pathway in Chinese Patients with Inflammatory Bowel Disease. (5th December 2013) Authors: Song, Lu; Zhou, Rui; Huang, Sha; Zhou, Feng; Xu, Shufang; Wang, Wei; Yi, Fengming; Wang, Xiaobing; Xia, Bing Other Names: Agrawal Anshu Academic Editor. Journal: Mediators of inflammation Issue: Volume 2013(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Potential mechanism of circRNA_000585 in cholangiocarcinoma. Issue 6 (June 2021) Authors: Yi, Fengming; Xin, Longxiang; Feng, Long Journal: Journal of international medical research Issue: Volume 49:Issue 6(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Erlotinib plus tivantinib versus erlotinib alone in patients with previously treated stage IIIb/IV non–small-cell lung cancer: A meta-analysis based on randomized controlled trials. Issue 25 (19th June 2020) Authors: Deng, Huan; Wang, Li; Chen, Xinling; Zhang, Shujuan; Yi, Fengming; Wei, Yiping; Zhang, Wenxiong Other Names: Ding. Jianxun section editor. Journal: Medicine Issue: Volume 99:Issue 25(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A meta-analysis comparing stereotactic body radiotherapy vs conventional radiotherapy in inoperable stage I non-small cell lung cancer. Issue 34 (21st August 2020) Authors: Li, Can; Wang, Li; Wu, Qian; Zhao, Jiani; Yi, Fengming; Xu, Jianjun; Wei, Yiping; Zhang, Wenxiong Other Names: Ding. Jianxun section editor. Journal: Medicine Issue: Volume 99:Issue 34(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗